2.
The application shall be signed by the sponsor or a representative of the sponsor. This signature shall confirm that the sponsor is satisfied that: the information provided is complete; the attached documents contain an accurate account of the information available; and the clinical trial will be conducted in accordance with the amended documentation.
← anx_II__cpt_1__point_1__text_1 · All articles · anx_II__cpt_1__point_2__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.